Results 81 to 90 of about 4,595,974 (209)

Oral anticoagulants for stroke prevention in nonvalvular AF [PDF]

open access: yes, 2017
YesWarfarin and direct oral anticoagulants (DOACs) have been shown to reduce the risk of stroke in patients with atrial fibrillation, yet many patients are still not being anticoagulated.
Petty, Duncan R.   +3 more
core   +1 more source

Status of anticoagulation therapy after initial bleeding during direct oral anticoagulants in patient with nonvalvular atrial fibrillation.

open access: yes, 2021
Status of anticoagulation therapy after initial bleeding during direct oral anticoagulants in patient with nonvalvular atrial fibrillation.
Takatsugu Yamamoto (6840838)   +11 more
core   +1 more source

Pharmacokinetic interactions between anticancer drugs and direct oral anticoagulants: clinical implications for safe anticoagulation

open access: yesBleeding, Thrombosis and Vascular Biology
Patients with cancer have an increased risk of thrombosis requiring anticoagulation. Direct oral anticoagulants have become the primary anticoagulant of choice in most patients with cancer. Patients with cancer also receive many concomitant medications,
Tzu-Fei Wang   +2 more
doaj   +1 more source

The Effect of Dicloxacillin Administration on Pharmacokinetics of Narrow Therapeutic Window Drugs: Phenytoin and Warfarin

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Dicloxacillin is a penicillinase‐resistant beta‐lactam antibiotic and potent activator of the Pregnane X receptor (PXR), known to induce CYP2C9, CYP2C19, and CYP3A4 activity. Clinical data suggest it reduces anticoagulation in warfarin‐treated patients and increases the risk of thromboembolic events.
Chanan Shaul   +5 more
wiley   +1 more source

Evaluation of bleeding in patients receiving direct oral anticoagulants

open access: yes, 2017
Erika L Hellenbart,1 Kathleen D Faulkenberg,2 Shannon W Finks3 1University of Illinois at Chicago College of Pharmacy, Chicago, IL, 2Cleveland Clinic, Cleveland, OH, 3University of Tennessee College of Pharmacy, Memphis, TN, USA Abstract: Direct oral ...
Faulkenberg KD, Hellenbart EL, Finks SW
core  

Safety profile evaluation of direct oral anticoagulants in surgical patients with polypharmacy: a retrospective analysis of clinical cases

open access: yesРеальная клиническая практика: данные и доказательства
This article presents the results of a safety study of oral anticoagulants in surgical patients with polypharmacy. An analysis of medical records of inpatients receiving oral anticoagulants for the prevention of venous thromboembolic complications was ...
E. R. Kadyseva, V. N. Khaziakhmetova
doaj   +1 more source

UMOD Genotype and Clinical Outcomes in Heart Failure Patients Treated with Loop Diuretics: A UK Biobank Pharmacogenetic Cohort Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Uromodulin (UMOD) regulates tubular sodium handling and modulates NKCC2, the molecular target of loop diuretics (LD). Although UMOD variants have been associated with blood pressure and hypertension, their pharmacogenetic relevance in heart failure (HF) remains unknown.
Reinhold Kreutz   +5 more
wiley   +1 more source

Medication adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65.

open access: yes, 2019
Medication adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65.
Hyungtae Kim (6970)   +3 more
core   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy